Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme

Affiliations

• ¹ Department of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany thomas.meyer@charite.de.
• ² Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany.
• ³ Department of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• ⁴ Department of Neurology, Center for ALS and other Motor Neuron Disorders, Alfried Krupp Krankenhaus, Essen, Germany.
• ⁵ Department of Neurology, Center for ALS and other Motor Neuron Disorders, Berufsgenossenschaftliches Universitatsklinikum Bergmannsheil, Bochum, Germany.
• ⁶ Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.
• ⁷ Department of Neurology, Translational Neurodegeneration Section Albrecht Kossel, Universitätsmedizin Rostock, Rostock, Germany.
• ⁸ Research Site Rostock/Greifswald, DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany.
• ⁹ Department of Neurology, Technische Universität Dresden, Dresden, Germany.
• ¹⁰ Research Site Dresden, DZNE, German Center for Neurodegenerative Diseases, Dresden, Germany.
• ¹¹ Department of Neurology, Hannover Medical School, Hannover, Germany.
• ¹² Department of Neurology, University of Ulm, Ulm, Germany.